Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1MOLECULAR AND CELLULAR BIOLOGYIF2.72023-03-2743OAAI
The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for DegradationMOLECULAR AND CELLULAR BIOLOGYIF2.72023-03-2145OAAI
ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In VivoMOLECULAR AND CELLULAR BIOLOGYIF2.72023-03-2169OAAI
Data-Driven Construction of Antitumor Agents with Controlled PolypharmacologyJOURNAL OF THE AMERICAN CHEMICAL SOCIETYIF15.62019-09-0912OAAI
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)JOURNAL OF MEDICINAL CHEMISTRYIF6.82019-02-1545OAAI
Highly Selective MERTK Inhibitors Achieved by a Single Methyl GroupJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-10-2225PREAI
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response肿瘤分泌的Pros1抑制巨噬细胞M1极化降低抗肿瘤免疫应答JOURNAL OF CLINICAL INVESTIGATIONIF13.62018-04-30129OA
Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors (vol 56, pg 9683, 2013)JOURNAL OF MEDICINAL CHEMISTRYIF6.82014-08-180PREAI
Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis (vol 56, pg 9693, 2013)JOURNAL OF MEDICINAL CHEMISTRYIF6.82014-08-180OAAI
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia (vol 3, pg 129, 2012)ACS MEDICINAL CHEMISTRY LETTERSIF42014-08-150OAAI
UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual InhibitorJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-08-06152OAAI
Inhibition of MerTK in tumor infiltrating leukocytes decreases tumor growth in a mouse model of breast cancerMOLECULAR CANCER RESEARCHIF4.72014-07-310PRE
Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-11-2071OA
Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of ThrombosisJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-11-2059OA
UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In VivoMOLECULAR CANCER THERAPEUTICSIF5.52013-11-0660OAAI
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasisJOURNAL OF CLINICAL INVESTIGATIONIF13.62013-07-08191OA
UNC1062, a new and potent Mer inhibitorUNC1062，一种新的有效Mer抑制剂EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92013-07-0194OAAI
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic LeukemiaACS MEDICINAL CHEMISTRY LETTERSIF42012-01-13111OAAI
HER4 D-Box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4CANCER RESEARCHIF16.62007-07-1718OAAI
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cellsMOLECULAR BIOLOGY OF THE CELLIF2.72006-09-0184OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项